Talasaz AmirAli 4

What Happened
Talasaz AmirAli, CEO of Guardant Health (GH), sold a total of 210,000 shares in multiple open-market transactions on May 20, 2026. The sales were executed in 12 tranches at prices reported between about $100.95 and $112.76 (footnotes indicate some trades in the full range up to $112.93), generating aggregate proceeds of approximately $23.08 million. This filing reports sales (transaction code S) rather than purchases or option exercises.

Key Details

• Transaction date: May 20, 2026; Form 4 filed May 22, 2026 (filed within the typical 2-business-day reporting window).
• Total shares sold: 210,000; Total proceeds: ~$23,076,690.
• Prices: individual tranches reported at weighted average prices from $100.95 up to $112.76; footnotes disclose more granular ranges across the tranches (roughly $102.29–$112.93 for grouped lots).
• Number of reported tranches: 12 separate sale entries.
• Shares owned after transaction: Not specified in the provided data.
• Notable footnotes: Several entries use weighted-average prices and state the Reporting Person will provide a breakdown of shares sold at each specific price on request. No 10b5‑1 plan, tax‑withholding, or gift language was disclosed in the summary provided.

Context
This was an open-market sale (liquidity event) by the CEO. Sales by insiders are common and can reflect personal liquidity needs or diversification; they are not, by themselves, definitive signals about the company’s outlook. Retail investors often watch insider purchases more closely as potential positive signals, while large sales should be noted but interpreted in context (holding levels, prior disclosures, and company fundamentals).